Drive payer submission readiness for Phase 2 and 3 product

In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

The partnership focuses on the expansion of real-time monitoring and other intelligence services.

A panel dives into the current and future outlook of healthcare policies.